responders aware of the project and perceiving an improvement in medication chart quality. All responders would like to see the project continue.
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Background: Intrapartum chemoprophylaxis reduces the incidence of early-onset group B streptococcal disease (EOGBSD) in newborns, a disease with estimated global incidence of 0.53 per 1000 live births. Some guidelines advise that intrapartum antibiotics should be offered following universal antenatal screening for GBS carriage, and others, based on clinical risk factors alone. Since 1999, Queensland guidelines (revised and published online in 2010) have recommended a modified risk-factor approach. This study explores the trend of EOGBSD in Queensland in the setting of these guidelines.
Methods: A state-wide retrospective population-based beforeand-after study was performed. Live infants born from January 2000 to December 2014 in whom GBS was cultured from blood or CSF within 7-days of age were identified through pathology database extraction, allowing near-complete, population-based case identifica- Methods: During the period between April 2011 and March 2013, neonates who were treated with whole body cooling in our NICU were enrolled. Head ultrasound was performed before and during TH. Brain MRI was arranged at 1-2 weeks of age. Bayley Scales of Infant Development, third edition (BSID-III) was used to assess neurodevelopmental (ND) outcome of survived infants at 2 years of age. ND delay was defined as scores of BSID-III <85 in any domain.
Results: Sixteen neonates were enrolled for analysis. Male to female ratio was 11:5 and cesarean section to vaginal delivery ratio was 12:4. Eight (50%) out of the 16 of neonates had cranial hemorrhage in this study including six patients (37.5%) with subgaleal hemorrhage (SH), one patient (6.3%) with mild subdural hemorrhage (SDH), one patient (6.3%) with brain parenchymal hemorrhage, and one patient (6.3%) with mild intraventricular hemorrhage, SDH and SH. Six (75%) out of the 8 neonates with cranial hemorrhage developed ND delay.
Conclusions: Cranial hemorrhage is not uncommon in neonates with HIE and treated with TH. Affected neonates were at high risk of ND delay. University, Melbourne, Australia Email: nalinchoudhary@hotmail.com Background: Neonatal units have started to switch from using conventional soy-based to alternate lipid emulsions, like SMOFlipid for preterm infants requiring parenteral nutrition. SMOFlipid has been associated with an improvement in biochemical parameters, and delay in progression of parenteral nutrition associated liver disease (PNALD), but there is paucity of literature on its effect on clinical outcomes.
INPATIENT OUTCOMES OF PRETERM INFANTS
Methods: This retrospective epoch study aimed to compare clinically relevant neonatal outcomes in preterm infants (<32 weeks), receiving SMOFlipid versus Intralipid. SMOFlipid was the primary lipid formula used during epoch 2 (July 2015 -March 2017), whilst
